BridgeBio Pharma, Inc. Payments for Repurchase of Redeemable Noncontrolling Interest
BridgeBio Pharma, Inc. (BBIO) reported Payments for Repurchase of Redeemable Noncontrolling Interest of $55.01 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-03.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest · last filed 2020-08-11
- BridgeBio Pharma, Inc. payments for repurchase of redeemable noncontrolling interest for the quarter ending 2019-12-31 was $0.00.
- BridgeBio Pharma, Inc. payments for repurchase of redeemable noncontrolling interest for the quarter ending 2019-09-30 was $26.38M.
- BridgeBio Pharma, Inc. payments for repurchase of redeemable noncontrolling interest for fiscal 2019 was $55.01M, a 24.36% increase from fiscal 2018.
- BridgeBio Pharma, Inc. payments for repurchase of redeemable noncontrolling interest for fiscal 2018 was $44.23M.
| Period end | Payments for Repurchase of Redeemable Noncontrolling Interest 3 month | Payments for Repurchase of Redeemable Noncontrolling Interest 6 month | Payments for Repurchase of Redeemable Noncontrolling Interest 9 month | Payments for Repurchase of Redeemable Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-03 | $26.38M derived: sum of 2 quarters · filed 2020-03-03 | $55.01M 10-K · filed 2020-03-03 | |
| 2019-09-30 | $26.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $55.01M 10-Q · filed 2019-11-08 | ||
| 2019-06-30 | $28.63M 10-Q · filed 2020-08-11 | |||
| 2018-12-31 | $44.23M 10-K · filed 2020-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |